The role of cells refractory to productive infection in acute hepatitis B viral dynamics
- PMID: 17360406
- PMCID: PMC1829262
- DOI: 10.1073/pnas.0603626104
The role of cells refractory to productive infection in acute hepatitis B viral dynamics
Abstract
During acute hepatitis B virus (HBV) infection viral loads reach high levels ( approximately 10(10) HBV DNA per ml), and nearly every hepatocyte becomes infected. Nonetheless, approximately 85-95% of infected adults clear the infection. Although the immune response has been implicated in mediating clearance, the precise mechanisms remain to be elucidated. As infection clears, infected cells are replaced by uninfected ones. During much of this process the virus remains plentiful but nonetheless does not rekindle infection. Here, we analyze data from a set of individuals identified during acute HBV infection and develop mathematical models to test the role of immune responses in various stages of early HBV infection. Fitting the models to data we are able to separate the kinetics of the noncytolytic and the cytolytic immune responses, thus explaining the relative contribution of these two processes. We further show that we need to hypothesize that newly generated uninfected cells are refractory to productive infection. Without this assumption, viral resurgence is observed as uninfected cells are regenerated. Such protection, possibly mediated by cytokines, may also be important in resolving other acute viral infections.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
The Role of Infected Cell Proliferation in the Clearance of Acute HBV Infection in Humans.Viruses. 2017 Nov 18;9(11):350. doi: 10.3390/v9110350. Viruses. 2017. PMID: 29156567 Free PMC article.
-
In silico single cell dynamics of hepatitis B virus infection and clearance.J Theor Biol. 2015 Feb 7;366:91-102. doi: 10.1016/j.jtbi.2014.11.020. Epub 2014 Dec 2. J Theor Biol. 2015. PMID: 25476731
-
Virion half-life in chronic hepatitis B infection is strongly correlated with levels of viremia.Hepatology. 2008 Oct;48(4):1079-86. doi: 10.1002/hep.22469. Hepatology. 2008. PMID: 18697217
-
Hepatitis B virus kinetics and mathematical modeling.Semin Liver Dis. 2004;24 Suppl 1:11-6. doi: 10.1055/s-2004-828673. Semin Liver Dis. 2004. PMID: 15192796 Review.
-
Small animal model systems for studying hepatitis B virus replication and pathogenesis.Semin Liver Dis. 2006 May;26(2):181-91. doi: 10.1055/s-2006-939760. Semin Liver Dis. 2006. PMID: 16673296 Review.
Cited by
-
Within-host mathematical models of hepatitis B virus infection: Past, present, and future.Curr Opin Syst Biol. 2019 Dec;18:27-35. doi: 10.1016/j.coisb.2019.10.003. Epub 2019 Nov 2. Curr Opin Syst Biol. 2019. PMID: 31930181 Free PMC article.
-
Relationship between serum HBsAg level, HBV DNA level, and peripheral immune cells in patients with chronic hepatitis B virus infection.Hepat Med. 2010 Nov 16;2:157-62. doi: 10.2147/HMER.S13796. eCollection 2010. Hepat Med. 2010. PMID: 24367213 Free PMC article.
-
The amount of hepatocyte turnover that occurred during resolution of transient hepadnavirus infections was lower when virus replication was inhibited with entecavir.J Virol. 2009 Feb;83(4):1778-89. doi: 10.1128/JVI.01587-08. Epub 2008 Dec 10. J Virol. 2009. PMID: 19073743 Free PMC article.
-
How robust are estimates of key parameters in standard viral dynamic models?PLoS Comput Biol. 2024 Apr 16;20(4):e1011437. doi: 10.1371/journal.pcbi.1011437. eCollection 2024 Apr. PLoS Comput Biol. 2024. PMID: 38626190 Free PMC article.
-
Modeling the acute and chronic phases of Theiler murine encephalomyelitis virus infection.J Virol. 2013 Apr;87(7):4052-9. doi: 10.1128/JVI.03395-12. Epub 2013 Jan 30. J Virol. 2013. PMID: 23365440 Free PMC article.
References
-
- Hollinger FB, Liang TJ. In: Fields Virology. 4th Ed. Knipe DM, Howley PM, editors. Philadelphia: Lippincott Williams & Wilkins; 2001. pp. 2971–3036.
-
- Lee WM. N Engl J Med. 1997;337:1733–1745. - PubMed
-
- Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV. Science. 1999;284:825–829. - PubMed
-
- Barker LF, Chisari FV, McGrath PP, Dalgard DW, Kirschstein RL, Almeida JD, Edgington TS, Sharp DG, Peterson MR. J Infect Dis. 1973;127:648–652. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials